Oramed Pharmaceuticals Inc (ORMP)

May 15, 2025

Oramed: Q1 Earnings Snapshot - MySA

May 15, 2025

May 13, 2025

Alpha Tau Medical appoints new board member By Investing.com - Investing.com India

May 13, 2025

May 12, 2025

Alpha Tau Medical appoints new board member - Investing.com

May 12, 2025

May 12, 2025

Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors - GlobeNewswire

May 12, 2025

Apr 29, 2025

Oramed Invests $36.9 Million In Alpha Tau For Strategic Growth - Finimize

Apr 29, 2025

Apr 29, 2025

Alpha Tau Medical (DRTS) Secures $36.9M in Direct Offering with Oramed Pharmaceuticals | DRTS Stock News - GuruFocus

Apr 29, 2025

Apr 28, 2025

Oramed invests $36.9 million in Alpha Tau cancer therapy By Investing.com - Investing.com

Apr 28, 2025

Apr 28, 2025

Alpha Tau Closes $36.9 Mln Offering And Forms Strategic Alliance With Oramed Pharmaceuticals - Nasdaq

Apr 28, 2025

Apr 28, 2025

Oramed Pharmaceuticals Announces $36.9 Million Investment And Strategic Collaboration With Alpha Tau Medical - marketscreener.com

Apr 28, 2025

Apr 28, 2025

Alpha Tau Announces Closing of $36.9 Million Registered - GlobeNewswire

Apr 28, 2025

Apr 28, 2025

Major Biotech Deal: Alpha Tau Medical Secures $36.9M Investment to Accelerate Cancer Treatment Innovation - Stock Titan

Apr 28, 2025

Apr 28, 2025

Oramed Closes $36.9M Strategic Investment in Alpha Tau Medical - citybiz

Apr 28, 2025

Apr 28, 2025

Alpha Tau's $37M Deal Unlocks Major Growth: 4 US Trials and Marketing Alliance Signal Expansion - Stock Titan

Apr 28, 2025

Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Apr 24, 2025

ORMPOramed Pharmaceuticals Inc Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025

Apr 21, 2025

What To Expect From Tesla’s (TSLA) Q1 Earnings - The Globe and Mail

Apr 21, 2025

Apr 10, 2025

Oramed stock hits 52-week low at $1.95 amid market challenges - Investing.com Australia

Apr 10, 2025

Apr 09, 2025

Oramed stock hits 52-week low at $1.95 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025

Mar 27, 2025

Oramed Pharmaceuticals Inc. (ORMP) reports earnings - qz.com

Mar 27, 2025

Mar 24, 2025

Oral Biologics Market Is Booming Worldwide 2025-2032 | Biocon - openPR.com

Mar 24, 2025

Mar 21, 2025

Oramed Pharmaceuticals Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView

Mar 21, 2025

Mar 13, 2025

Oramed Pharmaceuticals And 2 Other Penny Stocks With Promising Potential - Simply Wall St

Mar 13, 2025

Mar 12, 2025

Oramed Pharmaceuticals Stock Plummets After Insulin Test Results - The Wall Street Journal

Mar 12, 2025

Mar 11, 2025

Tianhui Biotech and Oramed Pharmaceuticals’ Investment in OraTech Pharmaceuticals - Global Legal Chronicle

Mar 11, 2025

Mar 08, 2025

AllPennyStocks.com Releases a Special Report on Oramed Pharmaceuticals Inc. - ACCESS Newswire

Mar 08, 2025

Mar 04, 2025

Oramed advances oral insulin, plans Phase 3 trial and dividend - Investing.com

Mar 04, 2025

Mar 04, 2025

Oramed advances oral insulin, plans Phase 3 trial and dividend By Investing.com - Investing.com South Africa

Mar 04, 2025

Mar 04, 2025

Oramed Pharmaceuticals Issues Letter to Shareholders - PR Newswire

Mar 04, 2025

Mar 03, 2025

ORMP stock touches 52-week low at $2 amid market challenges By Investing.com - Investing.com South Africa

Mar 03, 2025

Mar 03, 2025

ORMP stock touches 52-week low at $2 amid market challenges - Investing.com

Mar 03, 2025

Mar 01, 2025

Short Interest in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Expands By 149.0% - Armenian Reporter

Mar 01, 2025

Feb 28, 2025

OraMed Enters Global Licensing Deal for Lidocaine Product By Investing.com - Investing.com Australia

Feb 28, 2025

Feb 27, 2025

Oramed Pharmaceuticals (ORMP) to Release Quarterly Earnings on Wednesday - MarketBeat

Feb 27, 2025

Feb 27, 2025

OraMed Enters Global Licensing Deal for Lidocaine Product - Investing.com India

Feb 27, 2025

Feb 27, 2025

Rep. Brad Knott Sells Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Shares - MarketBeat

Feb 27, 2025

Feb 26, 2025

Congressional Trading Report: Rep. Brad Knott Sold Over $15K In Oramed Pharmaceuticals Stock - Benzinga

Feb 26, 2025

Feb 26, 2025

Congress Trade: Representative Brad Knott Just Disclosed New Stock Trades - Quiver Quantitative

Feb 26, 2025

Feb 22, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Downgraded to Sell Rating by StockNews.com - MarketBeat

Feb 22, 2025

Feb 17, 2025

227,239 Shares in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Acquired by Peapod Lane Capital LLC - MarketBeat

Feb 17, 2025

Feb 15, 2025

Oramed announces spinoff of protein drug technology - MSN

Feb 15, 2025

Feb 12, 2025

OraTech to pioneer oral insulin with $75 million investment - MSN

Feb 12, 2025

Feb 12, 2025

Oramed Pharmaceuticals : Ancillary Agreement Completion Protocol and Supplemental Agreement - Marketscreener.com

Feb 12, 2025

Feb 11, 2025

Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch - Simply Wall St

Feb 11, 2025